E-LIB Suche - Ergebnisse für: Nixon, Alan J.

1

Standardising long-term eel (Anguilla anguilla) fyke net su..:

Poole, Russell ; Minto, Cóilín ; Cooney, Joseph...
Fisheries Research. 272 (2024) - p. 106938 , 2024

Link: https://doi.org/10.1016/..

2

Common variation in a long non-coding RNA gene modulates va..:

Quintanilha, Julia C.F. ; Sibley, Alexander B. ; Liu, Yingmiao...
BMC Genomics. 25 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

3

Induction of durable remission by dual immunotherapy in SHI..:

Lim, So-Yon ; Lee, Jina ; Osuna, Christa E....
Science. 383 (2024) 6687 - p. 1104-1111 , 2024

Link: https://doi.org/10.1126/..

4

Exploration of the P1 residue in 3CL protease inhibitors le..:

Barton, Linda S. ; Callahan, James F. ; Cantizani, Juan...
Bioorganic & Medicinal Chemistry. 100 (2024) - p. 117618 , 2024

Link: https://doi.org/10.1016/..

5

Prognostic factors and predictive models in hot gallbladder..:

Tebala, Giovanni Domenico ; Shabana, Amanda ; Patel, Mahul...
Annals of Hepato-Biliary-Pancreatic Surgery. 28 (2024) 2 - p. 203-213 , 2024

Link: https://doi.org/10.14701..

6

Double dating sedimentary sequences using new applications ..:

Subarkah, Darwinaji ; Nixon, Angus L. ; Gilbert, Sarah E....
Lithos. 480-481 (2024) - p. 107649 , 2024

Link: https://doi.org/10.1016/..

7

CALGB 80802 (Alliance): Impact of Sorafenib with and withou..:

Abou-Alfa, Ghassan K. ; Geyer, Susan M. ; Nixon, Andrew B....
Cancer Research Communications. 4 (2024) 3 - p. 682-690 , 2024

Link: https://doi.org/10.1158/..

8

TABLE 2 from CALGB 80802 (Alliance): Impact of Sorafenib wi..:

Ghassan K. Abou-Alfa ; Susan M. Geyer ; Andrew B. Nixon...
doi:10.1158/2767-9764.25359897.v1. , 2024

Link: https://doi.org/10.1158/..

9

TABLE 2 from CALGB 80802 (Alliance): Impact of Sorafenib wi..:

Ghassan K. Abou-Alfa ; Susan M. Geyer ; Andrew B. Nixon...
doi:10.1158/2767-9764.25359897.v1. , 2024

Link: https://doi.org/10.1158/..

10

Supplementary Figure 3 from CALGB 80802 (Alliance): Impact ..:

Ghassan K. Abou-Alfa ; Susan M. Geyer ; Andrew B. Nixon...
doi:10.1158/2767-9764.25359909.v1. , 2024

Link: https://doi.org/10.1158/..

11

Supplementary Figure 4 from CALGB 80802 (Alliance): Impact ..:

Ghassan K. Abou-Alfa ; Susan M. Geyer ; Andrew B. Nixon...
doi:10.1158/2767-9764.25359906.v1. , 2024

Link: https://doi.org/10.1158/..

12

TABLE 1 from CALGB 80802 (Alliance): Impact of Sorafenib wi..:

Ghassan K. Abou-Alfa ; Susan M. Geyer ; Andrew B. Nixon...
doi:10.1158/2767-9764.25359903.v1. , 2024

Link: https://doi.org/10.1158/..

13

Supplementary Figure 4 from CALGB 80802 (Alliance): Impact ..:

Ghassan K. Abou-Alfa ; Susan M. Geyer ; Andrew B. Nixon...
doi:10.1158/2767-9764.25359906.v1. , 2024

Link: https://doi.org/10.1158/..

14

FIGURE 2 from CALGB 80802 (Alliance): Impact of Sorafenib w..:

Ghassan K. Abou-Alfa ; Susan M. Geyer ; Andrew B. Nixon...
doi:10.1158/2767-9764.25359924.v1. , 2024

Link: https://doi.org/10.1158/..

15

Supplementary Figure 2 from CALGB 80802 (Alliance): Impact ..:

Ghassan K. Abou-Alfa ; Susan M. Geyer ; Andrew B. Nixon...
doi:10.1158/2767-9764.25359915.v1. , 2024

Link: https://doi.org/10.1158/..